Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | EIF2C2 |
| Upstream (Parents) |
|---|
| (<<) ATP2C1 → EIF2C2 |
| (<<) CASP9 → EIF2C2 |
| (<<) DDX21 → EIF2C2 |
| (<<) DNAJA4 → EIF2C2 |
| (<<) DUSP1 → EIF2C2 |
| (<<) FGF5 → EIF2C2 |
| (<<) FOS → EIF2C2 |
| (<<) JUNB → EIF2C2 |
| (<<) KCTD5 → EIF2C2 |
| (<<) MAP2K3 → EIF2C2 |
| (<<) MAP3K7 → EIF2C2 |
| (<<) PPP2R5C → EIF2C2 |
| (<<) RRAS → EIF2C2 |
| (<<) SPPL2B → EIF2C2 |
| (<<) STK4 → EIF2C2 |
| (<<) TEX10 → EIF2C2 |
| (<<) THRB → EIF2C2 |
| (<<) TUBA1B → EIF2C2 |
| (<<) TUBA1C → EIF2C2 |
| Downstream (Children) |
|---|
| EIF2C2 → ARSD (>>) |
| EIF2C2 → FUT1 (>>) |
| EIF2C2 → GSTZ1 (>>) |
| EIF2C2 → HMGA2 (>>) |
| EIF2C2 → LRP8 (>>) |
| EIF2C2 → N4BP3 (>>) |
| EIF2C2 → PDK2 (>>) |
| EIF2C2 → PGF (>>) |
| EIF2C2 → POP1 (>>) |
| EIF2C2 → SEH1L (>>) |
| EIF2C2 → TK2 (>>) |
| EIF2C2 → WNT7A (>>) |
